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The immune response to tumors induced by murine leukemia viruses (MuLV) 1 in 
mice  includes  the  generation  of MuLV-immune  cytolytic T  lymphocytes  (CTL), 
which  are  specific for  the  immunizing  MuLV-induced  tumor cells  (1-4)  and  are 
actively involved in the immune rejection of the MuLV-induced tumor in vivo (5-8). 
The antigens recognized by MuLV-immune CTL on the tumor cell surface, however, 
have not yet been clearly identified. A problem in defining the specificities of MuLV- 
immune CTL has been the large degree of heterogeneity among CTL populations 
generated in vivo after the appearance of a tumor. 
Two surface-membrane components have been shown to play a  major role in the 
recognition  of the  tumor  target  cell  by  MuLV-immune  CTL:  (a)  viral  proteins 
expressed as constitutive elements of the tumor cell membrane  (1-4, 9-11)  and  (b) 
H-2 transplantation  antigens  (2-4,  12,  13). Studies (1,  2)  concerning infection with 
Friend MuLV, Moloney leukemia-sarcoma virus (MSV), or Rauscher MuLV indi- 
cated that MuLV-immune CTL recognized an antigen analogous to the serologically 
defined cross-reactive antigen expressed by cells infected with Friend,  Moloney, or 
Rauscher MuLV (FMR) (14). More recent studies have suggested that Friend MuLV- 
immune CTL (9) and MSV-immune CTL (10)  recognize an antigenic determinant 
expressed on the viral glycoprotein gp70, coded by the env gene of the infecting virus 
and  expressed  on  the  tumor  cell  membrane.  In  contrast,  other  studies  (3,  4,  15) 
concerning the immune response to Gross MuLV-induced tumors suggested that  in 
the Gross MuLV model the principal antigen recognized by CTL was analogous to 
the serologically defined Gross virus-associated cell-surface antigen (GCSA;  16), coded 
by the gag  gene of Gross  MuLV.  Extensive analyses  (1-4)  have shown  that  CTL 
generated against Friend, Moloney, or Rauscher MuLV-induced tumors, on the one 
hand, and Gross MuLV-induced tumors, on the other hand, can distinguish  FMR- 
like antigens from GCSA-Iike antigens. 
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The involvement of H-2 transplantation antigens in the recognition of tumor target 
cells by MuLV-immune CTL has also been established and has been submitted to 
immunogenetic analysis (2-4,  12,  13,  17). Two genes located in the major histocom- 
patibility gene complex, H-2K and H-2D, code for the H-2 antigens that are recognized 
in conjunction with virus-induced antigens by MuLV-immune CTL. Two independ- 
ent subpopulations of MuLV-immune CTL have been identified, one subpopulation 
recognizing viral antigens in association with H-2K antigen, and the other, with H- 
2D antigen  (3, 4,  13,  15,  17).  Moreover, a  recent study (17)  showed that  individual 
MuLV-induced tumors were capable of affecting the relative proportions of H-2K- 
and H-2D-specific CTL subpopulations as a  result of quantitative variations in the 
amounts of H-2K and H-2D antigens expressed on the tumor cell surface. 
This report concerns a  specificity analysis of CTL elicited by immunization with 
syngeneic Friend or Gross MuLV-induced tumors in BALB/c (H-2  a)  and  BALB.B 
(H-2  b)  congenic mice. Analytical studies performed with monoclonal CTL cultures 
indicated that MuLV-immune CTL were composed of highly heterogeneous subpop- 
ulations  of CTL.  Various  categories  of CTL  clones  were  identified,  including  a 
majority of clones tightly restricted in their cytolytic activity to the infecting MuLV 
and to their autologous H-2 haplotype. The remaining CTL clones had decreasing 
degrees  of specificity;  in  fact,  a  group  of Lyt-2.2-positive CTL  clones  showed  no 
discernible  pattern  of cytolytic specificity and  were  capable  of attacking  a  large 
number of target cells, including uninfected lymphoblasts. 
Materials and Methods 
Mice.  All mice were bred at HSpital Cochin, Paris, from breeding pairs originally provided 
by Dr.  F.  Lilly (Albert  Einstein  College of Medicine,  New York). The inbred H-2-congenic 
strains BALB/c (H-2  a) and BALB.B (H-2  b) were used. 
Tumor Cells.  Continuous leukemia cell lines induced by Gross, Friend, Rauscher, or Moloney 
MuLV in various strains of mice (Table I) were maintained as stationary suspension cultures 
in Eagle's minimal essential medium supplemented with 10% fetal bovine serum.  B.GV cells 
were induced by Gross MuLV (18), and HFL/b cells were induced by Friend MuLV (19) in 
BALB.B (H-2  b) mice. RBL-5 cells were induced by Rauscher MuLV in C57BL/6 (H-2  b) mice 
(20). C.GV and C.GV-300  cells were induced by Gross MuLV (17, 18); HFL/d cells were 
TABLE  I 
Description of the Tumor Cell Lines Used 
Described in 
Nomencla-  Expression of MuLV-  Inducing virus  H-2 hap-  Mouse strain  reference 
ture  induced antigens  lotype  of origin  number 
FMR  GCSA 
B.GV  -  +  Gross MuLV  b  BALB.B  18 
HFL/b  +  -  Friend MuLV  b  BALB.B  19 
RBL-5  +  -  Rauscher MuLV  b  C57BL/6  20 
C.GV  -  +  Gross MuLV  d  BALB/c  17,  18 
C.GV-300  -  +  Gross MuLV  d  BALB/c  18 
HFL/d  +  -  Friend MuLV  d  BALB/c  19 
LSTRA  +  -  Moloney MuLV  d  BALB/c  21 
K.GV  -  +  Gross MuLV  k  BALB.K  18 1052  MONOCLONAL TUMOR-SPECIFIC CYTOLYTIC  T  LYMPHOCYTES 
induced by Friend MuLV  (19);  and LSTRA cells were induced by Moloney MuLV  (21)  in 
BALB/c (H-2  a) mice. K.GV cells were induced by Gross MuLV (18) in BALB.K (H-2  ~) mice. 
Immunofluorescent Staining.  The surface phenotype of cloned CTL was established by immu- 
no  fluorescence techniques, as described elsewhere (22). Direct immunofluorescence was used to 
identify surface immunoglobulin with fluorescein-labeled rabbit IgG anti-mouse IgG and IgM 
(N. L. Cappel Laboratories Inc., Cochranville, PA). Indirect immunofluorescence was used to 
detect  Thy-l.2,  Lyt-l.2, and  Lyt-2.2  antigens  with  mouse  monoclonal  antibodies directed 
against these antigens (New England Nuclear, Boston, MA). 
Lymphocyte Cultures and  CTL  Clones.  MuLV-specific  CTL  were  generated  in  syngeneic 
secondary mixed leukocyte-tumor cell cultures (MLTC)  from spleen cells of primed mice, as 
described elsewhere (3, 11). CTL specific for H-2 alloantigens were generated in primary mixed 
leukocyte cultures (11).  CTL were maintained in continuous culture by repeated stimulation 
with x-irradiated tumor cells as a  source of antigen  (23).  In some experiments, conditioned 
medium containing interleukin 2 (IL-2; 24) was added to the lymphocyte cultures. Conditioned 
medium came from rat spleen cell cultures incubated with 5 #g/ml concanavalin A at 37°C for 
36 h. 
CTL clones were derived from lymphocytes harvested in MLTC and distributed in multiwell 
plates at limiting dilutions of 0.5 and  1.0 cells per well in 30% IL-2-conditioned medium and 
1 X 106 x-irradiated (3,000 rad) syngeneic spleen feeder cells. Starting on day 4 after distribution, 
the microplate cultures were submitted to daily microscopic inspection, and those cultures that 
presented single proliferating cell clusters were defined as lymphocyte clones. Cloning efficiency 
ranged from 64 to 77%. Each CTL culture was fed every 4-5 d with conditioned medium, and 
after 4 wk the clones were transferred into upright tissue culture flasks and expanded by the 
repeated addition of 30% conditioned medium, 3 ×  106 x-irradiated (3,000  rad) spleen feeder 
cells, and  1 ×  106 x-irradiated (5,000  rad) tumor cells as a source of antigen. Each CTL clone 
was assayed for cytotoxicity in triplicate on a panel of ~lCr-labeled tumor target cells. A CTL 
clone was considered positive if it induced the release of at least three times the background 
value of spontaneous SICr release from each individual tumor target cell. 
~lCr Release Cytotoxicity  Assay.  Cell-mediated antitumor cytolytic activity was detected using 
a modification (3) of the method of Brunner et al. (25). All assays were performed with 10,000 
5XCr-labeled tumor target cells and were terminated after 6-h incubation at 37°C. Spontaneous 
release values varied between 4 and 15% of the total incorporated label. Cytolytic activity was 
sometimes expressed in terms of lytic units (LU), with one LU being the number of lymphocytes 
necessary to lyse 50% of the target cells during the incubation period of the assay (7,  11, 23); 
results were expressed in terms of LU per 106 lymphoid cells. 
Inhibition Assays.  In some experiments, CTL specificity for target antigens was analyzed by  51  addition of varying numbers of competitor target cells to the  Cr release cytotoxicity assay (3, 
17). The percentage of inhibition of CTL-mediated cytotoxicity was calculated according to 
the formula: 
control -  experimental 
×  100, 
control 
where the specific cytotoxic activity was detected in positive control wells and the experimental 
cytotoxicity values were obtained from wells containing competitor target cells. 
Results 
Specificity ~f CTL  Generated against MuL V-induced Tumors in  Syngeneic ML TC.  The 
results  summarized  in  Fig.  1  confirm  and  extend  previous  results  (3)  concerning 
MuLV-specific CTL  generated in  secondary MLTC.  BALB.B  (H-2  b)  and  BALB/c 
(/-/-2  a) CTL generated against syngeneic Gross MuLV-induced tumor cells were most 
efficient in killing tumor cells of the same H-2 haplotype induced by Gross MuLV 
(Fig. 1 A and C). Tumor cells induced by other MuLV  (i.e., Rauscher MuLV-induced 
RBL-5  cells and  Friend  MuLV-induced  HFL/b  and  HFL/d  cells)  were  generally 
spared  from  lysis.  However,  an  unexpected  cross-reactivity of  high  intensity  was FERNANDO  PLATA  1053 
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FIG.  1.  Specificity of lysis mediated by BALB.B (H-2  b) and BALB/c(H-2 d) CTL directed against 
different MuLV-induced tumors. (A) BALB.B  anti-B.GV CTL; (B) BALB.B  anti HFL/b CTL; (C) 
BALB/c anti-C.GV-300 CTL; (D) BALB/c anti-LSTRA CTL. CTL were generated in syngeneic 
secondary MLTC, harvested after 6 d in culture, and assayed on 104 51Cr-labeled tumor cells in a 
6-h cyt0toxicity assay at various lymphocyte-to-target cell ratios. The tumor cells used as targets 
were Gross MuLV-induced B.GV (0, H-fi) and C.GV-300 (©, H-2  "t) cells; Friend MuLV-induced 
HFL/b (I, clone B2, H-2  b) and HFL/d (A, H-2  d) cells; Rauscher MuLV-induced  RBL-5 cells 
([[],/-/-26); and Moloney MuLV-induced LSTRA cells (&, H-2d). 
observed  when  BALB/c  anti-C.GV-300  and  BALB/c anti-C.GV  CTL  (specific  for 
Gross MuLV) were assayed on syngeneic LSTRA tumor cells  (induced by Moloney 
MuLV). On the other hand, analysis of BALB.B and BALB/c CTL directed against 
MuLV-induced tumors of the FMR group (Fig.  1 B and D) revealed a  high degree of 
avidity  among these  CTL  for tumor  target  cells  syngeneic  at  H-2  and  positive  for 
FMR antigen (i.e.,  RBL-5, HFL/b, LSTRA, and HFL/d tumor cells). FMR-positive, 
H-2-different  tumor target  cells  were spared,  as were tumor cells  induced  by Gross 
MuLV  (i.e., B.GV and C.GV-300 cells). 
The  data  summarized  in  Fig.  1  indicated  the  existence  of cross-reactivities  of 
variable  intensities;  the  strongest  cross-reactivity  was  observed  with  Gross  MuLV- 
specific BALB/c CTL (Fig.  1 C) assayed on Moloney MuLV-induced LSTRA tumor 
cells. This cross-reactivity was further analyzed by competitive inhibition of cytotox- 
icity:  BALB/c anti-C.GV  CTL were  mixed  with  ~aCr-labeled  C.GV-300  cells  (Fig. 
2 A)  or LSTRA cells  (Fig.  2 B), and  increasing amounts of unlabeled  tumor cells of 
different  origins  were  added.  The  results  suggested  the  existence  of multiple  CTL 
subsets  that  recognized  MuLV-induced  antigens  of different  identities.  One  CTL 
subset killed C.GV-300 cells only, whereas a second CTL subset appeared to recognize 
both  C.GV-300 and  LSTRA cells  (Fig.  2A).  A  third  subset  of BALB/c anti-C.GV 
CTL  lysed  both  C.GV-300  and  LSTRA  target  cells  and  seemed  to  escape  from 1
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restriction  by H-2 because the lysis of LSTRA cells was partially  inhibited  by Gross 
MuLV-induced B.GV (H-2  ~) cells and K.GV (H-2*) cells (Fig. 2 B). 
Establishment of MuL V-specific CTL in Continuous Culture.  In preparation  for cloning, 
the  best  conditions  for proliferation  and  long-term  culture  of MuLV-specific  CTL 
were determined.  Two independent  attempts were made  to establish  BALB.B anti- 
B.GV  CTL  in  continuous  culture  without  losing  their  cytotoxic  activity  directed 
against B.GV tumor cells. Spleen cells from BALB.B mice previously immunized with 
an inoculum of B.GV tumor cells were set in continuous culture by repeated exposure 
to  x-irradiated  B.GV  tumor  cells  and  culture  reinitiation  every  10  d  (Fig.  3A), 
according to a protocole developed previously (23). Lymphocyte proliferation reached 
a peak equivalent to  180% viable cell recovery 5 d after the second addition of B.GV 
cells and subsequently attained plateau values of 100% viable cell recovery. Cytolytic 
activity was detectable until day 40; however, starting on day 50 in culture, the B.GV- 
specific  CTL  subpopulation  degenerated  and  eventually  died  out,  leaving  a  T 
lymphocyte population that proliferated in the presence of tumor antigen  (i.e., B.GV 
cells)  but that had low cytolytic activity. 
An alternative  approach,  originally described by Ryser et al.  (26) and Baker et al. 
(27),  involved  the  repeated  addition  of x-irradiated  B.GV  cells  to  B.GV-immune 
lymphocytes in  the presence of conditioned  medium  containing  IL-2  (24).  Regular 
A 
i I 
2Oo "O 
0 
Days  in  culture 
F~G.  3.  Long-term culture ofBALB.B anti-B.GV CTL by multiple antigenic stimulation in MLTC 
(A) or by multiple stimulation with antigen and IL-2-conditioned medium (B). Arrows indicate the 
addition  of x-irradiated  B.GV tumor cells  as a  source of antigen upon culture reinitiation.  Stars 
indicate  the  addition  of 30%  IL-2-conditioned  medium  at  the  time  of culture  reinitiation.  Cell 
proliferation  was determined  by  viable  cell  counts in  0.1%  trypan blue.  Cytotoxic activity  was 
detected  using  104  n~Cr-labeled  B.GV  tumor target  cells  in  a  6-h  cytotoxicity  assay at  various 
lymphocyte-to-target cell  ratios.  LU were calculated  from the cytotoxicity curves and were stas- 
h  dardized to LU per 10  viable lymphocytes recovered from MLTC. 1056  MONOCLONAL TUMOR-SPECIFIC CYTOLYTIC  T  LYMPHOCYTES 
culture reinitiation with the combined addition of tumor antigen and IL-2 resulted in 
sustained cellular proliferation  (i,e.,  188-300% viable cell recoveries  (Fig. 3 B)  as well 
as in the indefinite survival of B.GV-specific CTL. This procedure was consequently 
chosen to maintain  MuLV-specific CTL clones in vitro. 
Generation and Specificities of CTL Clones  Lymphocyte populations  from secondary 
MLTC  were  restimulated  by  the  addition  of x-irradiated  tumor  cells  and  IL-2- 
conditioned medium and subsequently cloned by limiting dilution at 0,5 or 1.0 cells 
per  microplate  well,  Cultures  that  presented  single  proliferating  cell  clusters  upon 
daily microscopic inspection were defined as cell clones. After expansion and antigenic 
restimulation,  each clone was tested for cytotoxicity on a  panel of 5XCr-labeled tumor 
target  cells,  Fig.  4  shows  the  results  obtained  when  25  lymphocyte  clones  from 
BALB.B anti-B.GV  spleen  ceils  were assayed  for cytotoxicity on ~lCr-labeled  B.GV 
cells.  A  high  degree  of heterogeneity  was  observed  with  respect  to  the  cytolytic 
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F[o. 4.  Cytolytic activity of 25 lymphocyte clones derived from BALB.B  anti-B.GV CTL generated 
in syngeneic secondary MLTC. Cytotoxicity was detected on 104 51Cr-labeled B.GV cells in a 6-h 
assay; lymphocytes were tested at various cell concentrations, as indicated. FERNANDO PLATA  1057 
potential  of these  clones  because  they  ranged  from  clones  with  barely  detectable 
cytolytic activity  (i.e., clones 6, 8,  10,  18, and 22)  to cytotoxic clones whose activity 
was detected at ratios as low as  100  lymphocytes  per  10,000  tumor target cells (i.e., 
clones  1,  2,  3,  5,  7,  9,  11,  13,  15,  17,  19,  and  23).  The  cytotoxic  activity  of these 
lymphocyte clones varied in intensity  from one assay to the other and required the 
addition  of x-irradiated  B.GV  tumor  cells  and  IL-2-conditioned  medium  for  its 
maxium expression. 
Similar  patterns  of  reactivity  were  observed  with  CTL  clones  obtained  from 
BALB.B  (H-2  b)  lymphocytes  primed  against  syngeneic  Friend  MuLV-induced 
HFL/b  tumor  cells  and  with  BALB/c  (/-/-2 a)  lymphocytes  primed  against  Gross 
MuLV-induced  C.GV  cells.  Table  II  summarizes  the  results  obtained  with  92 
lymphocyte  clones  assayed  independently  on  a  panel  of SlCr-labeled  tumor  target 
cells. The clones were distributed into different groups according to their specificities. 
Thus, group I included the majority of CTL clones (i.e., 52-64%): these CTL attacked 
the  tumor  cell  against  which  they were initially  primed  and  not  any  of the  other 
tumor cells assayed. The CTL clones included in group II  (i.e., 5-16%)  were specific 
for the priming MuLV-induced  antigen  in apparent  association with an H-2 public 
specificity shared between H-2  b and H-2  a antigens. Group III included six CTL clones 
that attacked tumor cells induced by Gross, Rauscher, Friend, and Moloney MuLV, 
and  they  were  H-2  restricted.  Group  IV  included  only  one  CTL  clone  that  was 
obtained  from BALB.B  anti-B.GV  lymphocytes;  this clone was H-2  b restricted and 
recognized RBL-5 and HFL/b tumor cells of the FMR family but failed to recognize 
the immunizing Gross MuLV-induced  B.GV cells. The cytolytic clones included  in 
group V  showed a total lack of target specificity;  it was noteworthy that 33% of the 
TABLE II 
Viral and H-2 Specificities of CTL Clones 
BI  Cytotoxic activity detected on  Cr-labeled 
Initial  lymphocyte  Clone  B.GV  C.GV-300  K.GV  RBL-5  HFL/b  LSTRA  HFL/d 
culture  group  Gross  Gross  Gross  Rauscher  Friend  Moloney  Friend  Frequency* 
MuLV  MuLV  MuLV  MuLV  MuLV  MuLV  MuLV 
H.2  h  H.2  a  H.2  k  H.2  b  H.2  b  H.2  a  H.2  a 
BALB.B  anti-B.GV  (H-2  h  I  +  .....  0.64 (16/25) 
anti-Gros~  MuLV)  II  +  +  .....  0.12 (3/25) 
III  +  -  +  +  -  -  0.08 (2/25) 
IV  -  -  +  +  -  -  0.04 (1/25) 
V  +  +  +  +  +  +  +  0.12  (3/25) 
VI  ......  0 
BALB.B  anti-HFL/b  (H-2  h  I  -  NT'.~  NT  +  +  -  -  0.52 (13/25) 
anti-Friend  MuLV)  II  -  NT  NT  +  +  +  +  0.16 (4/25) 
III  +  NT  NT  +  +  -  -  0.12 (3/25) 
IV  +  NT  NT  ....  0 
V  +  NT  NT  +  +  +  +  0.16 (4/25) 
VI  -  NT  NT  ....  0.04 (1/25) 
BALB/c  anti-C.GV  (H-2  a  I  -  +  -  NT  NT  -  -  0.57  (24/42) 
anti-Gross  MuLV)  II  +  +  -  NT  NT  -  -  0.05 (2/42) 
III  --  +  --  NT  NT  +  +  0.02 (1/42) 
IV  -  -  -  NT  NT  +  +  0 
V  +  +  +  NT  NT  +  +  0.33 (14/42) 
VI  --  --  NT  NT  -  -  0.02 (1/42) 
Each CTL clone was tested for cytotoxicity three or four independent  times on the same panel of nlCrqabeled  target cells in 6-h assays. 
* Number of clones positive per total number of clones assayed. 
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clones obtained from BALB/c anti-C.GV lymphocytes fell into this category. Finally, 
among the 92 lymphocyte clones presented in Table II, only two lacked any detectable 
cytotoxic activity (group VI). Although the intensity of lysis varied from one cytotox- 
icity assay to another, the specificity pattern oflysis of these CTL clones was conserved 
throughout a period of 4-6 mo. These results thus established the existence of muhiple 
independent CTL subsets present among MuLV-specific lymphocytes harvested from 
syngeneic MLTC. 
Surface Membrane Markers.  Immunofluorescent analysis of the surface markers of 16 
CTL clones selected from all groups showed that  100% of the cells were negative for 
surface IgG or IgM but strongly positive for Thy-1.2 antigen, thus confirming their T 
lymphocyte nature.  In  addition,  these  clones  expressed  Lyt-2.2 antigen  and  were 
weakly positive for Lyt-l.2 antigen, as indicated by immunofluorescent inspection 
using monoclonal anti-Lyt-2.2 and anti-Lyt-2.1 antibodies. Consequently, the surface 
phenotype of these lymphocyte clones was IgG-IgM-Thy-l.2+Lyt-l.2+Lyt-2.2  +, irre- 
spective of the specificity of lysis of the clone. 
Discussion 
The present communication provides direct evidence as to the highly heterogeneous 
constitution  of  CTL  populations  generated  against  MuLV-induced  tumors  in 
BALB/c and BALB.B mice. This heterogeneity was previously suggested by studies 
concerning the specificity of MuLV-immune CTL (2, 3, 15, 17). Figs.  1 and 2 provide 
further examples of heterogeneity among Gross MuLV°, Friend MuuLV- and Molo- 
ney  MuLV-immune lymphocytes. Although  major  specificity was  apparently  re- 
stricted to tumor target cells expressing GCSA or FMR antigen and belonging to the 
same H-2 haplotype as the CTL, weak cytotoxic reactions were often observed that 
crossed these restriction barriers. An exceptionally high cross-reactivity was observed 
among BALB/c CTL sensitized  against  syngeneic Gross  MuLV-induced C.GV  or 
C.GV-300 leukemia cells when these CTL were assayed on Moloney MuLV-induced 
LSTRA cells.  The results obtained by competitive inhibition of CTL activity using 
unlabeled  tumor  cells  (Fig.  2)  suggested  that  LSTRA  cells  were  recognized  by  a 
particular subset of BALB/c anti-C.GV CTL. 
The systematic study of cloned MuLV-specific CTL established the existence of a 
large degree of heterogeneity among lymphocytes recovered from syngeneic MLTC. 
Heterogeneity was observed both with respect to the relative intensities of target cell 
lysis mediated by cloned CTL (Fig. 4) as well as to the specificity of lysis displayed by 
CTL clones (Table II). Studies by other laboratories concerning cloned T lymphocytes 
have also revealed a  high degree of heterogeneity among CTL in other models of 
immunity, including syngeneic MSV-induced tumors (28), syngeneic influenza virus- 
infected cells  (29), syngeneic hapten-conjugated lymphocytes (30), and H-2 alloanti- 
gens (31).  Moreover, Baker and collaborators (27) obtained monoclonal cytolytic T 
cell lines from lymphocytes of C57BL/6 (H-2  6) origin sensitized against an allogeneic 
(/-/-2  a)  Friend MuLV-induced tumor; specificity analysis of these monoclonal CTL 
lines indicated the coexistence of alloantigen-specific cytotoxic lymphocytes and of 
lymphocytes specific  for  Friend  MuLV-induced  antigens  expressed  on  syngeneic 
target cells. 
The majority of the CTL clones studied here (i.e., 52-64%)  were restricted to tumor 
target cells  syngeneic with respect  to H-2 and positive for the immunizing MuLV- FERNANDO PLATA  1059 
induced  antigen  (GCSA-  or FMR-related).  A  limited  degree of heterogeneity was 
observed with respect to the H-2 specificity of these CTL clones because they were 
themselves distributed among H-2K- and H-2D-specific  CTL, as described in detail 
recently  (17).  However,  clones  showing  diverse  degrees  of cross-reactivities  with 
unrelated MuLV-induced tumor cells were also detected. Some of these cross-reactiv- 
ities  (clone groups  II-IV,  Table  II)  could  be  explained by  the  existence of cross- 
reactive or "public" antigens on H-2 and viral proteins, such as have been described 
for antibody specificities (32,  33).  Alternatively, some of these cross-reactive clones 
could be directed against endogenous virus antigens  (33)  expressed concommitantly 
with  FMR  or GCSA  antigen  or against  H-2 alloantigens.  The CTL clones  in  the 
present study, however, did not show clear-cut specificities for H-2 alloantigens, such 
as  have  been  reported  for cloned  influenza  virus-specific CTL  (34)  and  for CTL 
obtained in other syngeneic models of immunity (27,  35, 36). 
CTL clones in group V  (Table II) lacked any discernible pattern of specificity and 
attacked all tumor target cells with which they were presented. These lymphocytes 
could be related to the CTL responsible for autoimmune, nonspecific cytolysis, Which 
is particularly evident among BALB/c mice (37). In this context, CTL clones in group 
V  from BALB/c anti-C.GV lymphocytes killed bacterial lipopolysaccharide (LPS)- 
induced lymphoblasts from normal uninfected BALB/c mice; CTL clones included 
in the other groups were negative when tested on the same blasts  (data not shown). 
The presence of an  unusually  high  number of these  "autoreactive" clones  among 
BALB/c anti-C.GV lymphocytes could explain the high degree of killing of Moloney 
MuLV-induced LSTRA tumor cells observed with these lymphocytes before cloning 
(Figs.  1 and  2).  In this same context, Haas and colleagues (30)  isolated CTL clones 
from  hapten-immune  spleen  lymphocytes  that  lacked  discernible  specificities and 
were capable of killing a  large number of different haptenated and nonhaptenated 
target lymphoblasts. Similarly, Baker et al.  (27)  isolated cytotoxic CTL clones with 
an  apparent  lack  of target  cell  specificity after cloning T  lymphocytes sensitized 
against an allogeneic Friend MuLV-induced tumor. 
Upon  immunofluorescent analysis,  the  lymphocyte clones  presented  in  Table II 
were seen to be negative for surface IgG and IgM, which indicated they were not B 
cells. The T cell nature of these cloned lymphocytes was confirmed by inspection with 
monoclonal antibodies:  100% of the cells observed were highly positive for Thy-l.2 
and Lyt-2.2 antigens and weakly positive for Lyt-l.2 antigen. The presence of these 
surface markers favored the classification of these cells as CTL (38)  and invalidated 
the hypothesis that some of these clones might consist of natural killer cells because 
natural killer cells have been shown to be negative for both Lyt-1 and Lyt-2 antigens 
(39). 
An interesting observation was that, among the 92 lymphocyte clones considered, 
only two lacked any discernible cytotoxic activity. This indicated that the protocole 
chosen to generate the lymphocyte clones was highly selective for cytolytic T  lympho- 
cytes. The positive selection for CTL probably occurred during the phase of multiple 
stimulation with antigen in MLTC before cloning. Previous studies (23) showed that 
after two successive stimulations with tumor antigen in MLTC, 83% of all cells were 
T  lymphocytes (as opposed to 35% in fresh spleen). Subsequent studies by Brunner et 
al.  (40)  indicated that the proportion of MuLV-specific CTL precursors was signifi- 
cantly increased  in  MLTC  after repeated  stimulation  with  syngeneic tumor  cells. 1060  MONOCLONAL  TUMOR-SPECIFIC CYTOLYTIC T  LYMPHOCYTES 
Finally, the combined addition of IL-2 and tumor antigen to long-term MLTC (26) 
resulted  in  the  selection of a  proliferating  lymphocyte population  that  was  highly 
enriched in tumor-immune CTL. Because CTL appear to be one of the lymphocyte 
subpopulations that respond preferential!y to the growth-stimulating activity of IL-2 
(24,  27,  31),  cloning  by limiting  dilution  at  very low  cell  concentrations  in  IL-2- 
conditioned  medium probably resulted  in  a  drastic selection of proliferating CTL. 
The possibility of obtaining long-lived cloned  populations of MuLV-immune CTL 
with  a  defined  and  constant  specificity  should  render  possible  the  biochemical 
definition of the principal target antigens recognized by these lymphocytes. 
Summary 
The  speeificities of cloned  cytolytic T  lymphocytes  (CTL)  were  studied  for the 
analysis of CTL populations generated against murine leukemia viruses (MuLV)  in 
H-2 congenie BALB/c (//-2  a) and BALB.B (H-2  b) mice. In particular, CTL generated 
in response to tumors induced by Gross MuLV and Friend MuLV were studied; these 
tumors  express  virus-induced  antigens  that  do  not  cross-react  and  that  can  be 
distinguished  from  each  other.  The  systematic  study  of  92  CTL  clones  clearly 
indicated that MuLV-immune CTL were highly heterogeneous with respect to both 
the  intensities  of  target  cell  lysis  that  they  mediated  and  to  their  specificity  of 
recognition of MuLV-induced  tumor target cells. Various categories of CTL clones 
were identified, ranging from CTL clones that were tightly H-2 restricted and specific 
for the immunizing tumor to CTL clones that  displayed  no discernible patterns of 
specificity and that attacked a large number of different target cells. In addition, the 
surface markers of these cloned CTL were defined, and the best conditions for their 
prolonged maintenance in culture were determined. The present data indicate that 
future efforts in the definition of target antigens recognized by tumor-specific CTL 
should be performed with monoclonal lymphocytes. 
The author is indebted to Dr. Sylvie Gisselbrecht  and Dr. Jean-Paul L~vy for their critical 
comments and suggestions concerning this manuscript. 
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